The global dental biomaterials market was estimated at USD 8.5 billion in 2021 and it is expected to surpass around USD 14.7 billion by 2030, poised to grow at a CAGR of 6.28% from 2022 to 2030.
Dental biomaterials include biocompatible synthetic materials and natural tissues to restore tooth decay, damage, and fractures problems. As the geriatric population worldwide affected by tooth decay is huge despite significant advances in tooth restoration and caries prevention, the rising incidence of tooth disorder continues to pose a considerable burden to healthcare. In such cases, biological materials play an important role in the restoration of the damaged tooth structure.
Also, increasing dental tourism and rising disposable income in developing countries are some of the major factors responsible for market growth during the assessment period. Further, due to the rising penetration of tooth implants, various companies are shifting their focus on research and development of dental biological materials. Also, the growing geriatric population and development in the field are some of the major factors contributing to the growth of the market.
North America dominated the market and accounted for about 36.0% of the market share in 2019. Growing government expenditure on oral health and increasing adoption of dental biological materials to produce implants is expected to be one of the major factors contributing to market growth in this region.
Whereas, Asia Pacific is anticipated to witness rapid growth during the forecast period due to improved regulatory framework, and an increase in the number of hospitals and clinics dealing in tooth disorders.This can be attributed to increased opportunities for players, especially in Japan, China, and India.
Scope of The Report
Report Coverage | Details |
Market Size in 2021 | USD 8.5 billion |
Revenue Forecast by 2030 | USD 14.7 billion |
Growth rate from 2022 to 2030 | CAGR of 6.28% |
Base Year | 2021 |
Forecast Period | 2022 to 2030 |
Segmentation | Type, application, end-use, region |
Companies Covered | Straumann Holding AG; Geistlich Pharma AG; Zimmer Biomet Holdings, Inc.; Danaher Corporation; Dentsply Sirona, Inc.; 3M Company; Royal DSM; Carpenter Technology Corporation; Kuraray Co., Ltd.; Medtronic PLC; Henry Schein, Inc.; Mitsui Chemicals, Inc.; Victrex PLC; Ivoclar Vivadent AG; GC Corporation |
Application Insights
Based on application the orthodontics segment accounted for the largest market share of 42.67% in 2019. The large share of this segment can be attributed due to the rising cases of tooth disorders, growing dental tourism, and increasing disposable income in developing countries. Implants are gaining popularity among patients and are considered as the first option for dental treatment.
End-use Insights
Dental laboratories accounted for the largest market share of 42.8% in 2019. The largest share of this segment can be attributed to the increasing number of dental practice, rising prevalence of tooth disorder, and increasing awareness regarding oral hygiene. The dental academies and research institutes segment is anticipated to witness the highest CAGR in the market over the forecast period.
Type Insights
In terms of revenue, the ceramic biomaterials type segment dominated the market with a share of 36.18% in 2019. The large share of this segment can be attributed to the rising penetration of dental implants and the increasing use of ceramic biomaterial in dentistry. The metallic biomaterials provide internal support to the biological tissues and are most widely used in dental implants. Other segments include metallic biomaterials, polymeric biomaterials, natural biomaterials, metal-ceramic biomaterials, and composite biomaterials.
The composite biomaterials segment is anticipated to witness the highest CAGR during the forecast period owing to recent technological development in the composite biomaterials. Also, the segment offers various opportunities to market players due to its low penetration in the market.
Regional Insights
North America dominated the market and accounted for a market share of 35.5% in 2019 and is anticipated to continue dominance over the forecast period. This is due to growing government expenditure on oral health, rising aging population, and increasing adoption of dental biomaterials for the production of dental products, and other implants. The rising number of dental hospitals and clinics is also one of the reasons responsible for industry growth in this region.
Asia Pacific is expected to hold a significant industry share over the forecast period due to the increasing incidence of tooth disorder. The region is one of the densely populated areas of the world holding the two most populous countries of the world– India and China, both as emerging global economic leaders. As per the Global Burden of Disease survey in 2018, the Asia Pacific showed a huge burden of oral diseases.
In this region, around 3 to 6.5 out of 10 persons suffer from oral diseases. With increasing durability, the burden of oral disease is bound to increase in the future. In addition, growing medical tourism in emerging economies is also expected to drive market growth in the region. Certain regions, such as the Middle East and Africa and Latin America are projected to exhibit lucrative growth in the near future due to the rapid growth of the industry in these regions.
Key Players
Market Segmentation
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Dental Biomaterials Market
5.1. COVID-19 Landscape: Dental Biomaterials Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Dental Biomaterials Market, By Type
8.1. Dental Biomaterials Market, by Type, 2022-2030
8.1.1 Metallic Biomaterials
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Ceramic Biomaterials
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Polymeric Biomaterials
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Metal-Ceramic Biomaterials
8.1.4.1. Market Revenue and Forecast (2017-2030)
8.1.5. Natural Biomaterials
8.1.5.1. Market Revenue and Forecast (2017-2030)
8.1.6. Composites Biomaterials
8.1.6.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Dental Biomaterials Market, By Application
9.1. Dental Biomaterials Market, by Application, 2022-2030
9.1.1. Implantology
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Orthodontics
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Prosthodontics
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. Others
9.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Dental Biomaterials Market, By End-use
10.1. Dental Biomaterials Market, by End-use, 2022-2030
10.1.1. Dental Hospitals and Clinics
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Dental Laboratories
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Dental Academies and Research Institutes
10.1.3.1. Market Revenue and Forecast (2017-2030)
10.1.4. Dental Product Manufacturers
10.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Dental Biomaterials Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Type (2017-2030)
11.1.2. Market Revenue and Forecast, by Application (2017-2030)
11.1.3. Market Revenue and Forecast, by End-use (2017-2030)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Type (2017-2030)
11.1.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.1.4.3. Market Revenue and Forecast, by End-use (2017-2030)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Type (2017-2030)
11.1.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.1.5.3. Market Revenue and Forecast, by End-use (2017-2030)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Type (2017-2030)
11.2.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.3. Market Revenue and Forecast, by End-use (2017-2030)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Type (2017-2030)
11.2.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.4.3. Market Revenue and Forecast, by End-use (2017-2030)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Type (2017-2030)
11.2.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.5.3. Market Revenue and Forecast, by End-use (2017-2030)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Type (2017-2030)
11.2.6.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.6.3. Market Revenue and Forecast, by End-use (2017-2030)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Type (2017-2030)
11.2.7.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.7.3. Market Revenue and Forecast, by End-use (2017-2030)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Type (2017-2030)
11.3.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.3. Market Revenue and Forecast, by End-use (2017-2030)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Type (2017-2030)
11.3.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.4.3. Market Revenue and Forecast, by End-use (2017-2030)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Type (2017-2030)
11.3.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.5.3. Market Revenue and Forecast, by End-use (2017-2030)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Type (2017-2030)
11.3.6.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.6.3. Market Revenue and Forecast, by End-use (2017-2030)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Type (2017-2030)
11.3.7.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.7.3. Market Revenue and Forecast, by End-use (2017-2030)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Type (2017-2030)
11.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.3. Market Revenue and Forecast, by End-use (2017-2030)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Type (2017-2030)
11.4.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.4.3. Market Revenue and Forecast, by End-use (2017-2030)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Type (2017-2030)
11.4.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.5.3. Market Revenue and Forecast, by End-use (2017-2030)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Type (2017-2030)
11.4.6.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.6.3. Market Revenue and Forecast, by End-use (2017-2030)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Type (2017-2030)
11.4.7.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.7.3. Market Revenue and Forecast, by End-use (2017-2030)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Type (2017-2030)
11.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.5.3. Market Revenue and Forecast, by End-use (2017-2030)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Type (2017-2030)
11.5.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.5.4.3. Market Revenue and Forecast, by End-use (2017-2030)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Type (2017-2030)
11.5.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.5.5.3. Market Revenue and Forecast, by End-use (2017-2030)
Chapter 12. Company Profiles
12.1. Straumann Holding AG
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Geistlich Pharma AG
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Zimmer Biomet Holdings, Inc.
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Danaher Corporation
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Dentsply Sirona, Inc.
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. 3M Company
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Royal DSM
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Carpenter Technology Corporation
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Kuraray Co., Ltd.
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Medtronic PLC
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms